Drugs / Tendoncel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03811145 | May 2014 → Nov 2015 | epicondylitis | Cell Therapy Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tendoncel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03811145 ↗ |
| Route | Topical | “Topically applied experimental gel - Tendoncel. 80ul applied once a day for 21 consecutive days.” NCT03811145 ↗ |